BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35701043)

  • 1. Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
    Erton ZB; Sevim E; de Jesús GR; Cervera R; Ji L; Pengo V; Ugarte A; Andrade D; Andreoli L; Atsumi T; Fortin PR; Gerosa M; Zuo Y; Petri M; Sciascia S; Tektonidou MG; Aguirre-Zamorano MA; Branch DW; Erkan D;
    Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35701043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies.
    Chauleur C; Galanaud JP; Alonso S; Cochery-Nouvellon E; Balducchi JP; Marès P; Fabbro-Peray P; Gris JC
    J Thromb Haemost; 2010 Apr; 8(4):699-706. PubMed ID: 20088936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
    de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
    BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
    Yelnik CM; Porter TF; Branch DW; Laskin CA; Merrill JT; Guerra MM; Lockshin MD; Buyon JP; Petri M; Sammaritano LR; Stephenson MD; Kim MY; Salmon JE
    Arthritis Rheumatol; 2016 Aug; 68(8):1964-9. PubMed ID: 26990620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
    Erton ZB; K Leaf R; de Andrade D; Clarke AE; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Atsumi T; Zhang Z; Cohen H; Ramires de Jesús G; Branch DW; Wahl D; Andreoli L; Rodriguez-Almaraz E; Petri M; Barilaro G; Zuo Y; Artim-Esen B; Willis R; Quintana R; Vendramini MB; Barber MW; Bertolaccini ML; Roubey R; Erkan D
    Lupus; 2022 Dec; 31(14):1770-1776. PubMed ID: 36206383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
    de Frémont GM; Costedoat-Chalumeau N; Lazaro E; Belkhir R; Guettrot-Imbert G; Morel N; Nocturne G; Molto A; Goulenok T; Diot E; Perard L; Ferreira-Maldent N; Le Besnerais M; Limal N; Martis N; Abisror N; Debouverie O; Richez C; Sobanski V; Maurier F; Sauvetre G; Levesque H; Timsit MA; Tieulié N; Orquevaux P; Bienvenu B; Mahevas M; Papo T; Lartigau-Roussin C; Chauvet E; Berthoux E; Sarrot-Reynauld F; Raffray L; Couderc M; Silva NM; Jourde-Chiche N; Belhomme N; Thomas T; Poindron V; Queyrel-Moranne V; Delforge J; Le Ray C; Pannier E; Mariette X; Le Guern V; Seror R;
    Lancet Rheumatol; 2023 Jun; 5(6):e330-e340. PubMed ID: 38251600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
    Sevim E; Zisa D; Andrade D; Sciascia S; Pengo V; Tektonidou MG; Ugarte A; Gerosa M; Belmont HM; Zamorano MAA; Fortin PR; Ji L; Efthymiou M; Cohen H; Branch DW; de Jesus GR; Andreoli L; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Roubey R; Bertolaccini ML; Erkan D; Barbhaiya M;
    Arthritis Care Res (Hoboken); 2022 Feb; 74(2):324-335. PubMed ID: 32986935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
    Gkrouzman E; Willis R; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Fortin PR; Gerosa M; Signorelli F; Atsumi T; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri MA; Cervera R; Knight JS; Efthymiou M; Cohen H; Bertolaccini ML; Erkan D; Roubey R;
    Lab Invest; 2023 Jun; 103(6):100147. PubMed ID: 37044248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
    Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcomes of women with antiphospholipid syndrome during pregnancy.
    Tao JJ; Adurty S; D'Angelo D; DeSancho MT
    J Thromb Thrombolysis; 2023 May; 55(4):751-759. PubMed ID: 36967425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.
    Le Thi Thuong D; Tieulié N; Costedoat N; Andreu MR; Wechsler B; Vauthier-Brouzes D; Aumaître O; Piette JC
    Ann Rheum Dis; 2005 Feb; 64(2):273-8. PubMed ID: 15647435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset preeclampsia - The impact of antiphospholipid antibodies on disease severity.
    Zemet R; Dulitzki M; Baum M; Ofer Friedman H; Morag I; Simchen MJ
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():79-84. PubMed ID: 34167038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study.
    Gibbins KJ; Tebo AE; Nielsen SK; Branch DW
    Lupus; 2018 Oct; 27(12):1903-1910. PubMed ID: 30028257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
    Sciascia S; Willis R; Pengo V; Krilis S; Andrade D; Tektonidou MG; Ugarte A; Chighizola C; Branch DW; Levy RA; Nalli C; Fortin PR; Petri M; Rodriguez E; Rodriguez-Pinto I; Atsumi T; Nascimento I; Rosa R; Banzato A; Erkan D; Cohen H; Efthymiou M; Mackie I; Bertolaccini ML;
    Thromb Res; 2019 Mar; 175():32-36. PubMed ID: 30685523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
    Zheng XJ; Deng XL; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 46(2):323-8. PubMed ID: 24743831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
    Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.